The Prediction of Anatomical Morphology of Primary Aldosteronism Using Serum 18-Hydroxycorticosterone Levels*
- 1 January 1985
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 60 (1), 67-73
- https://doi.org/10.1210/jcem-60-1-67
Abstract
Serum 18-hydroxycorticosterone, aldosterone, and potassium were measured under basal conditions in 34 patients with documented primary aldosteronism, 10 patients with essential hypertension, and 9 normal subjects. The results revealed that 22 of 23 patients with aldosterone-producing adenomas had 18-hydroxycorticosterone levels greater than 100 ng/ dl, and all 9 patients with idiopathic adrenal hyperplasia had plasma levels less than 100 ng/dl. Two patients with unusual macromicronodular hyperplasia of the adrenal glands had levels greater than 100 ng/dl. We found a significant relationship between serum potassium and the ratio of 18-hydroxycorticosterone to aldosterone in patients with idiopathic adrenal hyperplasia, but not in those with an aldosterone-producing adenoma. We conclude that measurement of serum 18-hydroxycorticosterone is a useful predictor of the etiology of primary aldosteronism.Keywords
This publication has 9 references indexed in Scilit:
- Single Dose Captopril as a Diagnostic Test for Primary Aldosteronism*Journal of Clinical Endocrinology & Metabolism, 1983
- MULTIPLE PLASMA STEROID-RESPONSES TO GRADED ACTH INFUSIONS IN PATIENTS WITH PRIMARY ALDOSTERONISM1981
- The Significance of Elevated Levels of Plasma 18-Hydroxycorticosterone in Patients with Primary Aldosteronism*Journal of Clinical Endocrinology & Metabolism, 1979
- Primary AldosteronismAnnals of Internal Medicine, 1979
- 18-Hydroxycorticosterone: A reviewThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Evidence Against Prolactin Stimulation of Aldosterone in Normal Human Subjects and Patients with Primary Aldosteronism, Including a Patient with Primary Aldosteronism and a Prolactin-Producing Pituitary MicroadenomaJournal of Clinical Endocrinology & Metabolism, 1977
- A New and Superior Adrenal Imaging Agent,131I-6ß-Iodomethyl-19-Nor-Cholesterol (NP-59): Evaluation in HumansJournal of Clinical Endocrinology & Metabolism, 1977
- Diagnosis and Nomenclature of the Disorders of the Terminal Portion of the Aldosterone Biosynthetic PathwayJournal of Clinical Endocrinology & Metabolism, 1976
- Suppression of Plasma Renin Activity in Primary AldosteronismJAMA, 1964